Method for removal of viruses from blood by lectin affinity hemodialysis
AssigneeAethlon Medical, Inc.
InventorRichard H. Tullis
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method for using lectins that bind to pathogens having high mannose surface glycoproteins or fragments thereof which contain high mannose glycoproteins, to remove them from infected blood or plasma in an extracorporeal setting. Accordingly, the present invention provides a method for reducing viral load in an individual comprising the steps of obtaining blood or plasma from the individual, passing the blood or plasma through a porous hollow fiber membrane wherein lectin molecules are immobilized within the porous exterior portion of the membrane, collecting pass-through blood or plasma and reinfusing the pass-through blood or plasma into the individual.
Claims13
A method of reducing viral particles and lectin binding fragments thereof in the blood of an individual infected with a virus, comprising the steps of:
- a) obtaining blood from the individual;
- b) passing the blood through a porous hollow fiber membrane, wherein lectin molecules are immobilized within a porous exterior portion of the membrane, and wherein the lectin molecules bind to high mannose glycoproteins;
- c) collecting pass-through blood;
- and
- d) reinfusing the pass-through blood into the individual.
A method of reducing viral load in the plasma of an individual infected with a virus, comprising the steps of:
- a) obtaining plasma from the individual;
- b) passing the plasma through a porous hollow fiber membrane, wherein lectin molecules are immobilized within a porous exterior portion of the membrane, and wherein the lectin molecules bind to high mannose glycoproteins;
- c) collecting pass-through plasma;
- and
- d) reinfusing the pass-through plasma into the individual.
Dependencies are inferred from the claim text.